# OnCo record paper-castroviejo-bermejo-embo-mol-med (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-castroviejo-bermejo-embo-mol-med/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-castroviejo-bermejo-embo-mol-med" ;
  schema:name "A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation"@en ;
  schema:description "Paper cited by one technology page, indexed on Europe PMC as PubMed record 30377213 and published in EMBO molecular medicine; the citing page links this DOI, which is how the record was matched."@en ;
  schema:url <https://onco.cc/key-papers/paper-castroviejo-bermejo-embo-mol-med/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.15252/emmm.201809172>, <https://pubmed.ncbi.nlm.nih.gov/30377213/>, <https://europepmc.org/article/MED/30377213> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.15252/emmm.201809172> ;
  schema:datePublished "2018"^^xsd:gYear ;
  schema:author "Castroviejo-Bermejo M, Cruz C, Llop-Guevara A, et al." ;
  onco:related <https://onco.cc/technologies/rad51-foci-assay/> .